McAloney, Camille A. http://orcid.org/0000-0001-9742-3648
Makkawi, Rawan http://orcid.org/0000-0002-8301-3688
Budhathoki, Yogesh http://orcid.org/0009-0009-1278-6278
Cannon, Matthew V. http://orcid.org/0000-0002-3035-9490
Franz, Emily M. http://orcid.org/0000-0001-8307-7887
Gross, Amy C. http://orcid.org/0000-0002-0123-5085
Cam, Maren http://orcid.org/0000-0002-6337-6414
Vetter, Tatyana A. http://orcid.org/0000-0002-9904-9140
Duhen, Rebekka
Davies, Alexander E. http://orcid.org/0000-0002-1917-8816
Roberts, Ryan D. http://orcid.org/0000-0001-5028-744X
Funding for this research was provided by:
NIH/NCI (T32CA009338, T32CA269052, R01CA260178)
Steps for Sarcoma Foundation
NIH/ORIP (K01OD031811)
Hyundai Hope on Wheels Young Investigator Award
CancerFree KIDS Foundation
Sarcoma Foundation of America
Nationwide Children’s Director’s Strategic Development Fund
NIH CTSA (UL1TR002733)
Translational Studies Grant from the Osteosarcoma Institute
Article History
Accepted: 23 August 2023
First Online: 7 September 2023
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: Human samples were collected from consented patients under an Institutional Review Board (IRB)-approved protocol (IRB11-00478) at Nationwide Children’s Hospital (Human Subject Assurance Number 00002860), or under IRB-approved protocol #22198 at Oregon Health and Science University by the Cancer Early Detection Advanced Research Center (CEDAR) Specimen and Data Repository, in line with the principles of the Declaration of Helsinki.All animal studies were approved by Nationwide Children’s Hospital Institutional Animal Care and Use Committee (IACUC protocol AR15-00022).